Stock Events

Stock Events

Alx Oncology 

$2.00
42
-$0.05-2.44% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
2
Day Low
1.99
52W High
2.66
52W Low
0.96
Volume
11,819
Avg. Volume
-
Mkt Cap
276.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.67
-0.49
-0.31
-0.13
Expected EPS
-0.131913
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-101.7MNet Income

Analyst Ratings

4.50Average Price Target
The highest estimate is 5.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALXO. It's not an investment recommendation.
NVIDIA
11
NVDA
Apple
9
AAPL
Amazon
7
AMZN
AMD
7
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a leading biopharmaceutical company that competes in the oncology space with a broad portfolio of cancer treatments, potentially overlapping with ALXO's focus areas.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is a global healthcare company that offers cancer treatments, including immunotherapies that could be in direct competition with ALXO's pipeline.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its Genentech subsidiary, develops a wide range of oncology drugs that could compete with ALXO's cancer therapies.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca PLC has a strong presence in the oncology sector, with several marketed products and a robust pipeline that could compete with ALXO's developments.
Pfizer
PFE
Mkt Cap159.99B
Pfizer Inc. is a global pharmaceutical company with a significant oncology portfolio, including therapies that might compete with ALXO's products.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences, Inc. is involved in the discovery, development, and commercialization of oncology products, potentially competing with ALXO in certain cancer indications.
AMGEN
AMGN
Mkt Cap237.52B
Amgen Inc. has a diverse oncology portfolio, including treatments for cancers that ALXO is also targeting, making them direct competitors.
Novartis
NVS
Mkt Cap301.95B
Novartis AG is a healthcare company with a strong emphasis on oncology, developing treatments that could directly compete with ALXO's cancer therapies.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals, Inc. is known for its innovative biotechnology products, including oncology treatments that could rival ALXO's pipeline.
Incyte
INCY
Mkt Cap25.91B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, including oncology, which places them in competition with ALXO.

About

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Show more...
CEO
Jason Lettmann
Employees
48
Country
United States
ISIN
US00166B1052

Listings

XNAS
US
ALXO
BOATS
BOATS
ALXO.BOATS

2 Comments

user2308@#

definitely. promising products in the pipeline

0
user2308@#

Alxo Oncology could be the surprise of the year among American penny stocks.

0

FAQ

What is Alx Oncology stock price today?▼
The current price of ALXO is $2.00 USD — it has decreased by -2.44% in the past 24 hours. Watch Alx Oncology stock price performance more closely on the chart.
What is Alx Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alx Oncology stocks are traded under the ticker ALXO.
Is Alx Oncology stock price growing?▼
ALXO stock has fallen by -1.96% compared to the previous week, the month change is a +2.56% rise, over the last year Alx Oncology has showed a +70.94% increase.
What is Alx Oncology market cap?▼
Today Alx Oncology has the market capitalization of 276.55M
When is the next Alx Oncology earnings date?▼
Alx Oncology is going to release the next earnings report on November 05, 2026.
What were Alx Oncology earnings last quarter?▼
ALXO earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.14 USD resulting in a +9.04% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alx Oncology revenue for the last year?▼
Alx Oncology revenue for the last year amounts to 0 USD.
What is Alx Oncology net income for the last year?▼
ALXO net income for the last year is -101.7M USD.
How many employees does Alx Oncology have?▼
As of August 30, 2026, the company has 48 employees.
In which sector is Alx Oncology located?▼
Alx Oncology operates in the Health & Wellness sector.
When did Alx Oncology complete a stock split?▼
Alx Oncology has not had any recent stock splits.
Where is Alx Oncology headquartered?▼
Alx Oncology is headquartered in SOUTH SAN FRANCISCO, United States.